Blood Run

Price Rationale

I set fair value at 182.5 ETH, below the comparable-sales 205 ETH view but well above the 105 ETH liquidity-exit mark. The exit appraisal is useful for downside because there is no live bid, ask, or OTC history, yet it overstates forced-sale pressure for a non-distressed January 2020 SuperRare XCOPY 1/1 with a clean 242.69 ETH exact sale. The cultural and USD-cycle views cluster near 180-185 ETH and better balance stale 2022 peak risk against durable trophy demand. CITIZENS!'s 87.8015 ETH OTC reset caps confidence, while 2024-2026 in-universe anchors around 164-255 ETH keep value in the high-100s.

What Caps The Price

I do not carry the value closer to 205-245 ETH because Blood Run lacks a current bid, listed ask, OTC confirmation, or grail flag. The 242.69 ETH exact sale remains important, but it occurred on 2022-01-03, and the nearest supplied peer later reset far lower in a 2024 OTC sale.

What Supports The Price

I do not follow the 105 ETH liquidity mark because it is closer to an urgent-exit estimate than fair market value. Blood Run has a real 242.69 ETH exact-token sale, early 2020 SuperRare provenance, one-owner custody, and nearby supplied anchors such as data_lords, NGMI, THE FUD, N, FOMO, and The Burning.